These pathways, such as programmed cell death protein 1 (PD-1)/programmed cell death 1 ligand 1 (PD-L1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), play a role in immunosuppression and evasion of the immune system by malignant tumors. This evidence concerns the gene CTLA4 and cancer.